SCHEMBL22459241

SCHEMBL22459241

C=C(COC)C(=O)OCCOc1ccc(-c2ccc(OCCOC(=O)C(=C)COC)c(OCCOC(=O)C(=C)COC)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 2/20 0.39
▸ PDE4B Q07343 2/20 0.39
▸ PDE4C Q08493 2/20 0.39
▸ PDE4D Q08499 2/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ POLB P06746 3/20 0.38
▸ CASP6 P55212 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ LMNA P02545 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ APEX1 P27695 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ACACB O00763 1/20 0.36
▸ ACACA Q13085 1/20 0.36
▸ HDAC3 O15379 3/20 0.36
▸ HDAC4 P56524 3/20 0.36
▸ HDAC1 Q13547 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459566 0.95 PPARG (0.37) PDE4APDE4BPDE4CPDE4DPPARG
SCHEMBL22561040 0.93 CHEK2 (0.38) PDE4APDE4BPDE4CPDE4DPPARG
SCHEMBL22459543 0.92 POLB (0.40) PDE4APDE4BPDE4CPDE4DPPARG
SCHEMBL22459285 0.92 EGFR (0.39) PDE4APDE4BPDE4CPDE4DPPARG
SCHEMBL22459860 0.91 EGFR (0.43) PPARGPPARDPPARAPOLBMAPT
SCHEMBL22459608 0.90 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL22459449 0.90 POLB (0.43) PPARGPPARDPPARAPOLBMAPT
SCHEMBL22459353 0.90 POLB (0.43) PPARGPPARDPPARAPOLBMAPT
SCHEMBL22459248 0.90 POLB (0.43) PPARGPPARDPPARAPOLBMAPT
SCHEMBL21422426 0.90 RARB (0.43) PPARGPPARDPPARAMAPTRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 PDE4A 4002/4885PDE4B 4162/4885PDE4C 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback